Recommended Global Microbiology Webinars & Conferences
Asia Pacific & Middle East
Viral Outbreaks 2017
Session/Tracks
ConferenceSeries Ltd invites all the participants from all over the world to attend ‘Annual Meeting on Viral Outbreaks and Epidemiology’ during October 16-18 in Baltimore, USA, which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
In the line with International Conference on Mycology, addressing the most recent advances across the spectrum of Virology research from basic sciences to public health, conference highlights will include General Virology and Basic Science, Respiratory and Emerging/Re-emerging Viruses, Advances in Techniques in Virology, Viral Immunology, Viral Infections, Therapeutic Approaches and Targets for Viral Infections, Agriculture and Plant Virology, Veterinary Virology, Current Focus in Virology Research, Viral Hepatitis, Zika Virus, Ebola Virus, HIV & Other Emerging Viruses, Pediatric Viral Diseases, Recent Advances in Drug Discovery.
ConferenceSeries Ltd Organizes 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50,000 eminent personalities, reputed scientists as editorial board members.
Featuring 3 days of Scientific workshop, Special sessions, Speaker & Poster session, Industrial Expo. 300+ attendees from all over the world.
Track 1: General Virology and Basic Science
The Americas commanded the most sizably voluminous share 42% of the Ecumenical Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.
A viral contamination is one of the real reasons for human and animal illness. Virus genomes are small and they are unimaginably different and subject to quick hereditary change. Virus have their own particular manners of transmission. The portability of animals builds the systems of viral transmittance that are advanced, while plants stay stable and in this way infections should depend on ecological components to be transmitted between hosts.
Relevant Conferences:
8th World Congress on Virology November 28-30, 2016 San Antonio, USA;4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Florida, USA; 2nd World Infectious Diseases Congress August 25-27, 2016; 10th Asia-Pacific Medical Virology conference,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany;6th European Congress of Virology,Oct 19-22,2016 Germany; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina. American Society for Microbiology , Society for General Microbiology, Society for Applied Microbiology, Canadian Society of Microbiologists
Track 2: Respiratory and Emerging/Re-emerging Viruses
As indicated by the U.S. Community for Disease Control and Prevention (CDC), Respiratory syncytial infection (RSV) is the basic reason for bronchiolitis or pneumonia in the youngsters under one year of age in the United States. Every year 75,000 to 125,000 kids are hospitalized because of RSV diseases.
An alphavirus has a place with the gathering IV Togaviridae group of infections according to the arrangement of grouping considering viral genome association displayed by David Baltimore. Filoviruses fit in with an virus family called Filoviridae and can bring about serious hemorrhagic fever in people and nonhuman primates. Picornaviruses are non-wrapped, positive-stranded RNA infections with an icosahedral capsid. West Nile infection is a mosquito-borne zoonotic arbovirus having a place with the genus Flavivirus in the family Flaviviridae.
Relevant Conferences:
2nd International Conference on Influenza September 12-14 2016, Germany; 2nd World Infectious Diseases Congress August 25-27 2016, USA; Annual Conference on H1N1 & Influenza Vaccines July 18-20 2016, USA; World Conference on Infection Prevention and Control November 28-29, 2016 Valencia, Spain; 4th InternationalBacteriology and Infectious Diseases Congress May 16-18 2016, Texas,USA; 5th Influenza Research & Development 2016, USA; Influenza Vaccines for the World October 6-9 October 2015, Portugal.World Veterinary Vaccine Congress November 9 - 11 2015, USA; Annual Influenza Update, September 17 2015, USA; Options IX for the Control of Influenza August 24-26 2016. International Society for Antiviral Research (ISAR),International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology
Track 3: Advances of Techniques in Virology
Virology also called as Virulogy explores the study of viruses and virus-like agents, their taxonomy, virulence, beneficial and molecular properties. Although it is part of microbiology, it has in itself evolved into a huge branch of study having own sub-fields. Viruses have primarily been considered in a negative context but their beneficial properties are being explored and utilized these days in various industries and in viral therapies.
Relevant Conferences:
2nd International Conference on Retroviruses and Novel Drugs, June 30- July 01, Cape Town, South Africa; World Congress on Microbiology, November 28-29, 2016 Valencia, Spain; 3rd Microbiologists Annual Meeting, August 15-17, 2016, Portland, Oregon, USA; 2nd World Congress on Infectious Diseases, August 24-26, 2016, Philadelphia, USA; 3rd Euro-Global Conference on Infectious Diseases, September 5-7, 2016, Frankfurt, Germany; World Congress on Infection Prevention and Control, September 5-6, 2016, Frankfurt, Germany; 7th International Congress on Clinical Virology, October 13-14, 2016, Manchester, UK, American Society for Virology , International Union of Microbiological Societies , Pan-American Society for Clinical Virology USA, Federation of European Microbiological Societies European Union, and European Society for Virology
Track 4: Viral Immunology
The global infectious immunology market is forecast to reach $8.8 billion by 2017, growing at a compound annual growth rate (CAGR) of 6% during the period 2010-2017. The hepatitis infections fragment developed at 7% and was esteemed at $2 billion in 2010.
Cell signaling is a part of an intricate arrangement of communication that directs basic cellular exercises and facilitates cell activities. A Neutralizing antibody is a counter acting agent which defends a cell from an antigen or infectious body by repressing or killing any effect it has naturally. Cell-mediated immunity is a resistant reaction that does not include antibodies, but instead includes the initiation of phagocytes, antigen-specific cytotoxic T-lymphocytes, and the arrival of different cytokines in response of an antigen.
Relevant Conferences:
2nd International Conference on Influenza September 12-14 2016, Germany; 2nd World Infectious Diseases Congress August 25-27 2016, USA; Annual Conference on H1N1 & Influenza Vaccines July 18-20 2016, USA; World Conference on Infection Prevention and Control November 28-29, 2016 Valencia, Spain; 4th InternationalBacteriology and Infectious Diseases Congress May 16-18 2016, Texas,USA; 5th Influenza Research & Development 2016, USA; Influenza Vaccines for the World October 6-9 October 2015, Portugal.World Veterinary Vaccine Congress November 9 - 11 2015, USA; Annual Influenza Update, September 17 2015, USA; Options IX for the Control of Influenza August 24-26 2016. International Society for Antiviral Research (ISAR),International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology
Track-5: Viral Infections
Viral infections are quite prevalent, most typically seen are the common cold, hepatitis, influenza, measles, rabies, Dengue, diarrhea, AIDS , polio, smallpox, cold sores and genital herpes, Study of various ways through which viruses affect individuals are specified as viral pathogenesis. The purview of the disease/ infection caused by the virus is its virulence. When a virus invades into the host, the immune system starts producing specific/ impromptu antibodies that binds to the virus thereby neutralizing its virulence or kills them. Presence of such antibodies in blood serum detects if a host has ever been exposed to any given virus in the past. This is possible only with the help of specific tests such as ELISA. Vaccinations protect against diseases, by augmenting the production of antibodies. Monoclonal antibodies, are profoundly specific to a single virus, are typically used for detection in fluorescence microscopy. Additionally, viruses being used as gene vectors in the gene therapy of genetic diseases are also gaining momentum; similarly in phage therapy, use of the bacteriophages to encounter bacterial infections and diseases was effectual. The recent approach of genetically engineered viruses in nanobiotechnology is seen as the novel approach to combat various diseases at the genetic level.
Due to the rampant HCV infection and high insistence for such enhanced and effectual treatments, numerous estimates envisage the global industry for HCV treatment costs $20 billion annually, this decade.
Relevant Conferences:
6th Clinical Microbiology Conference, October 20-22, 2016 Rome, Italy; International Conference and Expo onIndustrial Microbiology August 01-03, 2016 Frankfurt; European Microbiology Conference August 04-06, 2016 Frankfurt, Germany; 2nd International Conference on Parasitology August 01-03, 2016 Manchester, UK; International Conference on Mycology September 12-14 San Antonio, USA; 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2016) June 16-20, 2016 Boston, USA; Anaerobe 2016 July 11-14,2016 Nashville, USA; Microbe 2016, September 23-25, 2016 Sheffield, UK
Track 6: Therapeutic Approaches and Targets for Viral Infections
The Americas commanded the largest share 42% of the Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.
DNA inoculation is a novel strategy used to proficiently brace humoral and cell safe reactions to protein antigens. Viral antibodies contain either inactivated viruses or choked viruses .Inactive viral antibodies contain a virus, which have lost their capacity to replicate and in order for it to bring about a response it contains more antigen than live vaccinations. Allergy immunotherapy is a clinically archived effective treatment, which might impressively lessen the patient's allergic symptoms and the requirement for conventional, side effect soothing solution. Antiviral medications are a class of medicine used especially to treat viral contaminations.
Relevant Conferences:
3rd Global Microbiologists Annual Meeting August 15-17, 2016 Portland, USA;2nd World Congress On Beneficial Microbes ,September 23-25, 2016 Phoenix, USA; International Conference on Infectious Diseases & Diagnostic Microbiology Oct 3-5, 2016 Vancouver, Canada;International Microbial Physiology And Genomics ConferenceOctober 20-22, 2016 Rome, Italy; Microscopy Congress, 30th November - 1st December 2015, London, UK; New Approaches and Concepts in Clinical Microbiology,October 11 - 14, 2015, Heidelberg, Germany;19th International Conference on Recent Advances in Biomedical Science, January 9th, 2016, Kuala Lumpur, Malaysia; 3rd International Conference on Advances in Environment, Biomedical Sciences, January 12-13, 2016, Abu Dhabi,UAE. American Society for Microbiology , Society for General Microbiology, Society for Applied Microbiology, Canadian Society of Microbiologists
Track 7: Agriculture and Plant Virology
The agricultural inoculants market, in terms of value is anticipated to reach $398.56 million by 2019, at a CAGR of around 9.5% from 2014.
The study of disease transmission of plant virus diseases concerns the patterned improvement of virus diseases within plant population in time and space. Tobacco mosaic infection (TMV) is a positive-sense single stranded RNA virus that taints an extensive variety of plants, particularly tobacco and different individuals from the family Solanaceae. Mycology is the branch of science which manages the investigation of fungi, including their hereditary and biochemical properties, their scientific classification and their utilization to people as a source for tinder, drug, wine and entheogens, and also their threats, for example, harming or disease.
Relevant Conferences:
4th International Plant Genomics Conference, July 14-15, 2016 Brisbane, Australia; Global Summit on Plant Science, October 06-08, 2016 London, UK; 5th International Conference on Agriculture and Horticulture, June 27-29, 2016 Cape Town, South Africa; International Plant Physiology Conference, June 9-11, 2016 Dallas,USA; XIIIth International Plant Virus Epidemiology Symposium,June 6-10,2016 ,France; Australasian Plant Pathology Conference,September 14-16,2016 Fremantle, Western Australia; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada.International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology
Track 8: Veterinary Virology
The global animal healthcare market was esteemed at USD 27,861.2 million in 2013 and is expected to grow at a CAGR of 7.1% from 2014 to 2019, to achieve an expected estimation of USD 41,929.1 million in 2019.
Veterinary virology is the investigation of viruses in animals. It is a critical branch of veterinary medicine. A emerging virus is a term connected to a new found virus, one that is increasing in occurrence or with the possibility to increment in rate. Zoonotic diseases /contamination's are those which can be actually transmissible from vertebrate animals to humans. Prion disease represents to a group of conditions that influence the nervous system in humans and animals.
Relevant Conferences:
8th World Virology Meeting November 28-30, 2016 San Antonio, USA; 4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Florida, USA; 2nd World Infectious Diseases Congress August 25-27, 2016; 32nd Clinical Virology Symposium, May 19-22,2016 Florida, USA; 32nd Clinical VirologySymposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium onNeuroVirology,2016, Canada. American Society for Microbiology , Society for General Microbiology, Society for Applied Microbiology, Canadian Society of Microbiologists
Track 9: Current Focus in Virology Research
The global stem cell therapy market over the forecast period of 2015 to 2020. The business is ready to grow at a CAGR of 39.5% from 2015 to 2020, to achieve $330million by 2020.
Stem cell therapy is the utilization of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem cell therapy, but some therapies derived from umbilical cord blood are also in use. Clinical or medical virology is a branch of medicine which consists in isolating and/or in characterizing one or several viruses responsible for some human pathologies by various different immediate or circuitous systems.
Relevant Conferences:
5th International Conference and Exhibition on Cell & Gene Therapy, May 19-21, 2016, San Antonio, USA; 7th Annual Conference on Stem Cell and Regenerative Medicine, Aug 4-6, 2016, Frankfurt, Germany; 10thInternational Conference on Molecular & Cellular Cardiology, Aug 22-24, 2016, Sao Paulo, Brazil; 2nd International Conference and Exhibition on Tissue preservation and Bio-banking, Aug 18-19, 2016, Portland, Oregon; Molecular and Cellular Basis of Growth and Regeneration, January 10-14, 2016 , Colorado, USA; Phacilitate Cell & Gene Therapy World, January 25-27, Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease, 1-3 February 2016, Dresden, Germany; Craniofacial Morphogenesis & Tissue Regeneration, March 13-18, 2016, California, USA; Keystone Stem Cells and Cancer, March 6-10, 2016 Colorado, USA. International Society for Antiviral Research (ISAR), International Society for NeuroVirology,European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology.
Track 10: Viral Hepatitis
Due to the widespread infection of HCV and demand for these enhanced treatments, multiple estimates forecast the global market for HCV treatment will reach $20 billion yearly before the decade's get over.
Hepatitis is a therapeutic condition characterized by the inflammation of the liver and described by the presence of inflammatory cells in the tissue of the organ. Hepatitis A is an extraordinary overwhelming disease of the liver created by the hepatitis A virus. Hepatitis B is an infectious disease brought about by the hepatitis B infection (HBV) which influences the liver. It can bring about both serious and chronic infections. HCV is spread fundamentally by blood-to-blood contact associated with intravenous medication use, insufficiently cleaned therapeutic gear, and transfusions.
Relevant Conferences:
3rd World Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 2nd International Conference on Hepatology, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology, May 09-11, 2016,USA ; World Pathology Congress, June 16-18, 2016, Spain; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Latin and Ibero American Congress of PaediatricGastroenterology, Hepatology and Nutrition, November 18-21, 2015, Lima, Peru; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France ; 12th Congress of E-AHPBA, May 23-26, 2017, Mainz, Germany; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA.American Society for Microbiology , Society for General Microbiology, Society for Applied Microbiology,Canadian Society of Microbiologists
Track 11: Zika Virus
Zika virus is a member of the virus family Flaviviridae and the genus Flavivirus. It is spread by daytime-activeAedes mosquitoes, such as A. aegypti and A. albopictus The infection, known as Zika fever or Zika virus disease, often causes no or only mild symptoms, similar to a very mild form of dengue fever. While there is no specific treatment, paracetamol (acetaminophen) and rest may help with the symptoms. As of 2016, the illness cannot be prevented by medications or vaccines. Zika can also spread from a pregnant woman to her foetus. This can result in microcephaly, severe brain malformations, and other birth defects. Zika infections in adults may rarely result in Guillain–Barré syndrome.
Relevant Conferences:
Global Medical Microbiology Summit &Expo, November 28-30,2016; International Conference on Water Microbiology & Novel Technologies- July 18-20, 2016 Chicago, USA; 3rd Microbiologists Annual meeting -August 15-17, 2016 Portland, USA; 2nd world congress on Beneficial Microbe -September 23-25, 2016 Phoenix, USA; Microbial Physiology conference- September 29-30, 2016; London, UK; Infectious Diseases Conference- Oct 3-5, 2016 Vancouver, Canada; International Conference on Medical Parasitology 2016 , October 17-19, 2016, Houston, USA; International Conference on Human Papillomavirus – October 20-21, 2016, Chicago, USA; Clinical Microbiology Conference- October 24-26, 2016 Rome, Italy; 7th World Congress on Applied Microbiology, November 10-12, 2016 Istanbul, Turkey, Microbiology Society , International Union of Microbiological Societies , American Society for Microbiology USA, Federation of European Microbiological Societies European Union, and The Royal Society of Pathologists UK.
Track 12: Ebola virus
Ebola virus disease (EVD), also known as Ebola haemorrhagic fever (EHF) or simply Ebola, is a viral haemorrhagic fever of humans and other primates caused by Ebola viruses. Signs and symptoms typically start between two days and three weeks after contracting the virus with a fever, sore throat, muscular pain, and headaches. Then, vomiting, diarrhoea and rash usually follow, along with decreased function of the liver and kidneys. At this time some people begin to bleed both internally and externally.
Relevant Conferences:
International Conference on Medical Parasitology 2016 , October 17-19, 2016, Houston, USA; International Conference on Human Papillomavirus – October 20-21, 2016, Chicago, USA; Clinical Microbiology Conference- October 24-26, 2016 Rome, Italy; 7th World Congress on Applied Microbiology, November 10-12, 2016 Istanbul, Turkey, Microbiology Society , International Union of Microbiological Societies , American Society for Microbiology USA, Federation of European Microbiological Societies European Union, and The Royal Society of Pathologists UK. Global Medical Microbiology Summit &Expo, November 28-30,2016; International Conference on Water Microbiology & Novel Technologies- July 18-20, 2016 Chicago, USA; 3rd Microbiologists Annual meeting -August 15-17, 2016 Portland, USA; 2nd world congress on Beneficial Microbe -September 23-25, 2016 Phoenix, USA; Microbial Physiology conference- September 29-30, 2016; London, UK; Infectious Diseases Conference- Oct 3-5, 2016 Vancouver, Canada.
Track 13: HIV and Other Retroviral Diseases Affecting Afro-Asian Continents
The global HIV/AIDS market, including branded products and generics, was esteemed at $11.3 billion in 2010. This market is expected to reach $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate (CAGR) over the 2011-2016 estimate period to reach $14.1 billion in 2016.
The human immunodeficiency virus is a lentivirus that causes HIV disease and AIDS.HIV diagnosis is done by testing your blood or saliva for antibodies to the virus. HIV/AIDS clinical trials are exploration done to have improved approach, recognize, or treat HIV/AIDS. Clinical trials are the quickest approach to figure out whether new restorative ways to deal with HIV/AIDS are safe and effective in individuals.
Relevant Conferences:
8th World Virology Meeting November 28-30, 2016 San Antonio, USA; 4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Florida, USA; 2nd World Infectious Diseases Congress August 25-27, 2016; 32nd Clinical Virology Symposium, May 19-22,2016 Florida, USA; 32nd Clinical VirologySymposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium onNeuroVirology,2016, Canada. American Society for Microbiology , Society for General Microbiology, Society for Applied Microbiology, Canadian Society of Microbiologists
Track 14: Pediatric Viral Diseases
EAC anticipates that the viral industry will elevate from previous ecumenical/global size of $4.2 billion to $6.9 billion this year (2016), indicating a compound annual growth rate (CAGR) of about 10.6%
Viral diseases are supposedly the dire adjudge for juvenile forlornness and fatality across the globe. In a myriad of developing nations in the South-East Asia and Western Pacific, the emphasis on various health nuisances assimilates profound respiratory contaminations, diarrhoeas and arbour-viral diseases. Research conducted on these diseases demonstrates that there are no momentous discrepancies in the aetiological agents that are comprised or in the arrayal of clinical juvenile disease. Myocarditis is a disease of both adult and paediatric patients; it is an inflammatory disorder, customarily caused by viral infections. Hand-foot and mouth disease, herpangina, aseptic meningitis & pleurodynia are prevalent viral diseases in paediatric patients.
Relevant Conferences:
Global Medical Microbiology Summit &Expo, November 28-30,2016; International Conference on Water Microbiology & Novel Technologies- July 18-20, 2016 Chicago, USA; 3rd Microbiologists Annual meeting -August 15-17, 2016 Portland, USA; 2nd world congress on Beneficial Microbe -September 23-25, 2016 Phoenix, USA; Microbial Physiology conference- September 29-30, 2016; London, UK; Infectious Diseases Conference- Oct 3-5, 2016 Vancouver, Canada; International Conference on Medical Parasitology 2016 , October 17-19, 2016, Houston, USA; International Conference on Human Papillomavirus – October 20-21, 2016, Chicago, USA; Clinical Microbiology Conference- October 24-26, 2016 Rome, Italy; 7th World Congress on Applied Microbiology, November 10-12, 2016 Istanbul, Turkey, Microbiology Society , International Union of Microbiological Societies , American Society for Microbiology USA, Federation of European Microbiological Societies European Union, and The Royal Society of Pathologists UK.
Track 15: Recent Advances in Drug Discovery
The worldwide business sector for drug discovery technologies and products reached $38.4 billion in 2011. It is expected to expand to $41.4 billion in 2012 and to $79.0 billion in 2017, a compound annual growth rate (CAGR) of 13.8% somewhere around 2012 and 2017. Another report by visiongain, an independent media company based in London, predicts that the world market for drug discovery outsourcing will reach $16.6 billion in 2015.
Drug-drug interactions occur when a drug interacts, or interferes, with another drug modify the way one or both of the drugs act in the body, or cause unexpected side effects. The drugs involved can be prescription medications, over-the-counter medicines and even vitamins and natural products.
Relevant Conferences:
2nd International Conference and Expo on Drug Discovery & Designing, November 08-09, 2016 Istanbul, Turkey; Structure Based Drug Design Conference, February 21–24, 2016, USA; 8th International Conference and Exhibition on Pharmaceutics and Novel Drug Delivery Systems March 07-09, 2016, Spain; 11th Annual Fragment-Based Drug Discovery, April 20-21, 2016, USA; Drug Discovery and Therapy World Congress May 11-14, 2016, USA; 4th Annual conferences on European Pharma Congress June 13-15, 2016, Germany; 9th World Drug Delivery Summit June 30-July 02, 2016, USA; 7th International conference and exhibition onPharmacovigilance and Clinical Trials September 19-21, 2016, Austria; International Conference and Expo onGeneric Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016, Spain. International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV),Swedish Society of Medical Microbiology.
About Conference
ConferenceSeries Ltd invites all the participants from all over the world to attend ‘Annual Meeting on Viral Outbreaks and Epidemiology’ during October 16-18 in Baltimore, USA, which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
In the line with International Conference on Mycology, addressing the most recent advances across the spectrum of Virology research from basic sciences to public health, conference highlights will include General Virology and Basic Science, Respiratory and Emerging/Re-emerging Viruses, Advances in Techniques in Virology, Viral Immunology, Viral Infections, Therapeutic Approaches and Targets for Viral Infections, Agriculture and Plant Virology, Veterinary Virology, Current Focus in Virology Research, Viral Hepatitis, Zika Virus, Ebola Virus, HIV & Other Emerging Viruses, Pediatric Viral Diseases, Recent Advances in Drug Discovery.
ConferenceSeries Ltd Organizes 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50,000 eminent personalities, reputed scientists as editorial board members.
Featuring 3 days of Scientific workshop, Special sessions, Speaker & Poster session, Industrial Expo. 300+ attendees from all over the world.
Market Analysis
Summary:
Viral Outbreaks-2017 welcomes attendees, presenters, and exhibitors from all over the world to Baltimore. We are delighted to invite you all to attend and register for the “Annual Meeting on Viral Outbreaks and Epidemiology” which is going to be held during October 16-18, 2017 Baltimore, USA.
The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Outbreaks-2017, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Outbreaks-2017 organizing committee are looking forward to meet you in San Antonio, USA.
For more details please visit- http://viraloutbreaks.conferenceseries.com/
Importance & Scope:
Virology is the study of viruses – sub microscopic, parasitic particles of genetic material contained in a protein coat and virus-like agents. Virology is often considered a part of microbiology or of pathology. Viruses and viral diseases have been at the centres of science, agriculture, and medicine for millennia and some of our greatest challenges and triumphs have involved virology. Our virology conference is bringing experts from the field of virology for discussion of the latest advances and ideas and to stimulate interdisciplinary interactions. Conference like ours will help to speed up of the development of effective therapies for viral disorders.
Why Baltimore USA?
Baltimore is a major city in Maryland with a long history as an important seaport. Fort McHenry, birthplace of the U.S. national anthem, “The Star-Spangled Banner,” sits at the mouth of Baltimore’s Inner Harbor. Today, this harbor area offers shops, upscale crab shacks and attractions like the Civil War–era warship the USS Constellation and the National Aquarium, showcasing thousands of marine creatures.
Conference Highlights:
· General Virology and Basic Science
· Respiratory and Emerging/Re-emerging Viruses
· Advances in Techniques in Virology
· Viral Immunology
· Viral Infections
· Therapeutic Approaches and Targets for Viral Infections
· Agriculture and Plant Virology
· Veterinary Virology
· Current Focus in Virology Research
· Viral Hepatitis
· Zika Virus
· Ebola virus
· HIV and Other Retroviral Diseases Affecting Afro-Asian Continents
· Paediatric Viral Diseases
· Recent Advances in Drug Discovery
Why to attend???
It will provide a very good exposure to the on-going researches in Virology and related science. It will also provide insight to the novel inventions and techniques. It is very beneficial for the students and fellowship owners because it provides knowledge in the field. It also gives opportunities to the companies to showcase their products and have face to face meetings with scientists increasing their business opportunities. It also gives companies to know about their market competitors.
A Unique Opportunity for Advertisers and Sponsors at this International event: http://viraloutbreaks.conferenceseries.com/sponsors.php
Top Societies and Associations in USA
· Pan American Society for Clinical Virology
· International Society for Antiviral Research
· Infectious Diseases Society of America
· American Society for Virology
· Top Societies and Association around the World
· Global virus network
· HIV Medicine Association
· International AIDS Society
· Canadian Society for International Health
· Center for Emerging Viral Infections Research
· Hunter Medical Research Institute
· Center for Global Research and Intervention in Infectious Diseases
· Infectious and Immunologic Diseases Research Center
Target Audience:
· Scientists
· Research Scholars
· Associate Professors
· Professors
· Lecturers
· M.Sc Students
· Pharmaceutical Industries
· Healthcare Industries
· Directors of Associations and Societies
Past Conference Report
Virology-2011
Past Reports Gallery Virology -2012
Past Reports Gallery Virology-2013
Past Reports Gallery Virology-2014
Past Reports Gallery Virology-2015
Past Reports Gallery
To Collaborate Scientific Professionals around the World
Conference Date October 16-18, 2017
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Supported By
Virology: Current Research
Virology & Mycology
Virology & Antiviral Research
Journal of Medical Microbiology & Diagnosis
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by